318. Citrin deficiency
2 clinical trials, 2 drugs (DrugBank: 2 drugs), 0 gene, 0 pathway
Searched query = "Citrin deficiency", "NICCD", "Adult-onset type II citrullinemia", "CTLN2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000038114 | 2020-09-15 | 2020-09-11 | Molecular Diagnostic Study and Clinical Management of citrin deficiency | Molecular Diagnostic Study and Clinical Management of citrin deficiency | Citrin deficiency | Gold Standard:Sanger sequncing;Index test:Next-Generation Sequncing; | Beijing Friendship Hospital Affiliated to Capital Medical University | NULL | Recruiting | Both | Target condition:60;Difficult condition:0 | N/A | China | ||
| 2 | JPRN-jRCTs041190017 | 31/07/2012 | 10/04/2019 | Confirmation of effects of medium chain triglyceride therapy for citrin deficiency | Confirmation of effects of medium chain triglyceride therapy for citrin deficiency, especially in patients with symptomatic post neonatal intrahepatic cholestasis and that with adult-onset type II citrullinemia | citrin deficiency Endocrinology and Metabolism, Pediatrics;D006111 | Medium chain triglyceride 5-15ml 3 times a day | Mitsui Tetsuo | NULL | Recruiting | Not applicable | 80age | Both | 50 | Phase 2 | Japan |